Clin2
NCT07513116Possibly a fitNot yet recruiting

Intermittent Fasting for People at High Risk of Pancreatic Cancer

EvaluatingIntermittent FastingPancreatic Cancer

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This study tests whether eating within a limited time window each day (intermittent fasting) might help protect people who have a high risk of developing pancreatic cancer. Researchers will monitor participants through a clinic and have them track their eating patterns using an app.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been evaluated by a pancreatic cancer screening clinic and determined to be at high risk
  • You are willing to change when you eat (fast during certain hours) and stick with it
  • You are able to use an app to track your fasting times throughout the study
  • You have a healthy weight (BMI of 18.5 or higher)
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04607096Recruiting
Intermittent fasting to improve insulin in prediabetes or early type 2

This study tests whether intermittent fasting can improve how your body releases and uses insulin if you have prediabetes or early type 2 diabetes. It may help your blood sugar control without using insulin.

Berlin
NCT06122896Recruiting· Early Phase 1
Screening for pancreatic cancer in high-risk people

This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.

Boston, Massachusetts
NCT01102556Recruiting
Pancreas disease registry for people at risk or with pancreatic cancer

This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.

New York, New York
NCT05013216Recruiting· Phase 1
Vaccine trial for people at high risk of pancreatic cancer

This early-phase trial studies a long-peptide vaccine designed for people with certain genetic changes that raise the risk of pancreatic cancer. The goal is to help your immune system recognize and respond to cancer-related changes before cancer develops.

Baltimore, Maryland
NCT04760847Not yet recruiting
Intermittent fasting for recurrent pancreatitis symptoms

This trial studies whether periods of intermittent fasting can help people with recurrent pancreatitis. It may be aiming to improve pancreas-related function and symptoms, especially in people with ongoing digestive enzyme problems.

Tampa, Florida
NCT06271291Recruiting
Pancreatic Cancer Detection Study for High-Risk People

This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.

Scottsdale, Arizona

Hear when a new Intermittent Fasting trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.